Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient
Video Credit: Geo Beats - Duration: 00:45s - Published
Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient
Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.
Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead... Reuters India - Published Also reported by •IndiaTimes
Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now..
Credit: Wochit Entertainment Duration: 00:35Published
Delhi reported 3,788 new coronavirus cases over the past 24 hours, government data showed Wednesday evening, taking the total number of cases in the national capital to 70,390 and overtaking Mumbai..
![Maker of COVID-19 drug Remdesivir says it will cost about $3,000 per patient [Video]](https://video.newsserve.net/300/v/20200630/2006300313-Maker-of-COVID-19-drug-Remdesivir-says-it.jpg)
![Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]](https://video.newsserve.net/300/v/20200630/2006300205-Gilead-to-Charge-120-Per-Patient-for.jpg)
![Coronavirus: Delhi crosses 70,000 Covid-19 cases with 3,788 new patients in 24 hours | Oneindia news [Video]](https://video.newsserve.net/300/v/20200624/1308545699-Coronavirus-Delhi-crosses-70-000-Covid-19-cases.jpg)
